Validity of an Actigraph Accelerometer Following Critical Illness
NCT ID: NCT03295630
Last Updated: 2019-10-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2016-09-19
2017-04-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy Activity Monitors for Inhospital Activity Monitoring of Geriatric Patients
NCT04865627
MOTIONPODTM Validation in Free-living Conditio
NCT03235583
Hospital Based Continuous Patient Monitoring System
NCT06739447
Gait Analysis Parameter and Upper Limb Evaluation in Control Participants
NCT07136506
Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways
NCT05181111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will undertake a semi-structured movement protocol consisting of typical activities undertaken by this population. These include lying in bed, transferring over the side of the bed, sit to stand postural transfers (and the reverse), sitting in a chair and walking. Observation periods will not exceed 3 hours. During this time all aspects of the movement protocol will be completed.
The data from this study will be analysed to determine the validity of the Actigraph GT3X in identification of body position and quantification of step count using the placement sites described above.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Actigraph GT3X accelerometer
Ward based patients recovering from critical illness will wear two accelerometers placed on the thigh and ankle of the non-dominant leg
Accelerometer
Participants will perform a semi-structured movement protocol to investigate the ability of the Actigraph GT3X accelerometer to identify body position (lying, sitting or standing) and quantify step count.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Accelerometer
Participants will perform a semi-structured movement protocol to investigate the ability of the Actigraph GT3X accelerometer to identify body position (lying, sitting or standing) and quantify step count.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2\. Ventilated in excess of 48 hours during admission in the Intensive Care Unit (ICU).
3\. Currently resident on a hospital ward (secondary care) following step down from ICU
4\. Able to undertake all postural transfers independently or with minimal assistance (one person only).
5\. Able to mobilise short distances, either independently or with assistance from a walking aid or one person.
6\. Willing to permit application of two Actigraph GT3X accelerometers Each device weighs 27g with dimensions of 3.8cm x 3.7cm x 1.8cm.
7\. Willing to consent to a period of direct observation for a length of time not exceeding three hours.
Exclusion Criteria
2. Unwilling to consent to a period of observation not exceeding three hours.
3. Unable to make an informed decision about participation or demonstrating an inability to interpret information or follow study instructions
4. Significant neurological or coordination impairment
5. Unable to speak or understand English.
6. Clostridium Difficile/ similar infection or unmanaged urinary incontinence.
7. Evidence/ diagnosis of peripheral vascular disease.
8. Lower limb amputation
9. Polytrauma which prevents the adoption or normal lying, sitting or standing postures, or placement of the accelerometers
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hull University Teaching Hospitals NHS Trust
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jayne Anderson, GradDipPhys
Role: PRINCIPAL_INVESTIGATOR
Hull University Teaching Hospitals NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hull and East Yorkshire Hospitals NHS Trust
Hull, East Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Publication arising from the study found in the Journal Clinical Rehabilitation. Title: A study investigating the validity of an accelerometer in quantification of step count in adult hospital inpatients recovering from critical illness.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R1978
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.